Abby Wright
FOUNDER & CEO
Abby Wright, founder & CEO of PHAZE 4, recognized that companies struggle to remove access barriers for their products at every phase. Hiring an experienced, full-time Market Access employee is both expensive and often not feasible. Fractional Market Access leadership and services was the answer and how PHAZE 4 was born.
Abby is experienced and knowledgeable across a number of sectors in health care, including diagnostic laboratory and genetic testing, digital health, digital biomarker solutions, operations, reimbursement, managed care, health economics and business development including partnership development and alternative revenue streams. Prior to founding PHAZE 4 Medical, she served as Vice President of Business Development & Market Access at binx health, Inc. and as Vice President of Market Access at Biodesix, Inc. She is a graduate of Universidad de Alcala de Madrid, Spain, with a Master’s of Bilingual & Mulicultural Studies. She received her Bachelor of Decision Sciences and Bachelor of Spanish Language from Carnegie Mellon University, Pittsburgh, PA.
Kalli Glanz
PARTNER
Partner, at PHAZE 4 Medical, Kalli leads clients through commercialization and market access strategies. Kalli comes from leading consulting group, ADVI Health. She has a background in precision medicine, MolDX reimbursement, digital health, and point-of-care molecular diagnostics for both FDA-approved and Laboratory Developed Tests (LDTs). She specialized in government contracting and has worked closely with state departments of health to launch public health programs. She has also worked at the Ministry of Health in New Zealand where she coordinated policies to address the Sustainable Development Goals. Kalli earned her Bachelor of Arts & Science from McGill University with a degree in Sustainability, Science, and Society and specialties in Health Geography and Multidisciplinary Research.